wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36676379-5F337F1E-C564-4B94-BD73-633E4A6D8A44
Q36676379-5F337F1E-C564-4B94-BD73-633E4A6D8A44
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36676379-5F337F1E-C564-4B94-BD73-633E4A6D8A44
Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s
P2860
Q36676379-5F337F1E-C564-4B94-BD73-633E4A6D8A44
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36676379-5F337F1E-C564-4B94-BD73-633E4A6D8A44
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e20f56a97c039aabd609007a8b792575d47b00dc
P2860
Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses.